Therna Biosciences
PrivateLast Round
Seed
Aug 26, 2025
Total Funding Raised
$10M
Company Overview
Therna Biosciences is a biotechnology company that has developed a biology-guided, AI-powered platform to design and engineer programmable RNA therapeutics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Foundation
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Therna Biosciences Comparables
Compare Therna Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Noara Therapeutics | 85% | |
| Creyon Bio | 85% | |
| Eclipsebio | 82% | |
Therna Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Aug 26, 2025 |
Key People
Founding team and executive leadership
Therna Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Fusion Fund | Seed |
| Pear VC | Seed |
| AIX Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 26, 2025
$10M round led by AIX Ventures.
Therna Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Therna Biosciences's valuation, stock price, and market status.